ContextVision AB (publ) (OSL:CONTX)
4.560
+0.010 (0.22%)
Sep 12, 2025, 4:25 PM CET
ContextVision AB Revenue
ContextVision AB had revenue of 29.58M SEK in the quarter ending June 30, 2025, a decrease of -12.48%. This brings the company's revenue in the last twelve months to 115.59M, down -16.04% year-over-year. In the year 2024, ContextVision AB had annual revenue of 130.84M, down -1.33%.
Revenue (ttm)
115.59M SEK
Revenue Growth
-16.04%
P/S Ratio
2.87
Revenue / Employee
2.89M SEK
Employees
40
Market Cap
352.80M NOK
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 130.84M | -1.76M | -1.33% |
Dec 31, 2023 | 132.60M | 9.39M | 7.62% |
Dec 31, 2022 | 123.21M | 23.69M | 23.81% |
Dec 31, 2021 | 99.52M | 4.77M | 5.04% |
Dec 31, 2020 | 94.75M | -566.00K | -0.59% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 628.08M |
Nordhealth AS | 578.17M |
Photocure ASA | 522.86M |
ArcticZymes Technologies ASA | 104.33M |
Vistin Pharma ASA | 452.25M |
Omda AS | 458.96M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |